Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04116385 · ClinicalTrials.gov registry record
Evaluation of the Quantra System in a Surgical Oncological Population
A clinical trial, sponsored by HemoSonics.
- Completed
- Registry status
- 75
- Enrollment target
NCT04116385: Completed study, sponsored by HemoSonics.
NCT04116385 is a clinical trial that has completed, run by HemoSonics. The registered enrollment target is 75 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04116385 has completed, sponsored by HemoSonics.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
Study Summary
This study will monitor coagulation parameters during the perioperative course of cancer surgical procedures using the Quantra System with the QPlus Cartridge.
Primary Outcome
Coagulation function assessed by Quantra and TEG 5000
Interventions
- DIAGNOSTIC_TEST Quantra System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2019-08-15 |
| Est. Completion | 2020-07-30 |
What the finished NCT04116385 record still lists
NCT04116385 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Quantra System is the first listed.
NCT04116385 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04116385 about?
NCT04116385 is a clinical study titled "Evaluation of the Quantra System in a Surgical Oncological Population". This study will monitor coagulation parameters during the perioperative course of cancer surgical procedures using the Quantra System with the QPlus Cartridge.
What is the current status of trial NCT04116385?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2019-08-15. Estimated completion is 2020-07-30.
What interventions are being tested in trial NCT04116385?
The interventions under investigation include: Quantra System (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04116385?
This trial is sponsored by HemoSonics, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI